IngentaConnect BNCT for recurrent intracranial meningeal tumours case reports

Authors: Stenstam, B. H.¹; Pellettieri, L.; Sorteberg, W.²; Rezaei, A.; Sköld, K.³

Source: Acta Neurologica Scandinavica, Volume 115, Number 4, April 2007 , pp. 243-247(5)

Abstract:

Stenstam BH, Pellettieri L, Sorteberg W, Rezaei A, Sköld K. BNCT for recurrent intracranial meningeal tumours - case reports.

The investigation was designed to explore the efficacy of boron neutron capture therapy (BNCT) as treatment for recurrent intracranial meningeal tumours. Materials and methods -

Three patients with meningeal tumours, recurring after initial surgery, radiation therapy and several reoperations, were evaluated for treatment with BNCT by determination of the accumulation of boronophenylalanine fructose (BPA-F) in tumour and in surrounding tissue. Two of these patients were subsequently treated by BNCT. Results -

The present results indicate that BNCT could be effective in prolonging time to recurrence, and thus in extending survival time, for patients with recurrent intracranial meningeal tumours. Conclusions -

BNCT is potentially an effective radiation treatment modality for malignant intracranial meningeal tumours, which could increase progression-free survival, thus reducing the need for additional surgical interventions. Indications for BNCT would be even larger if recurrent grade II meningiomas could be treated, as indicated by the results of the boron uptake study.

Keywords: BNCT; meningeal tumours; survival

Document Type: Research article

DOI: 10.1111/j.1600-0404.2006.00776.x

Affiliations: 1: Nyköping Hospital, County of Sormland, Sweden 2: Department of Neurosurgery, Rikshospitalet-Radiumhospitalet Trust, Oslo, Norway 3: Hammercap Medical AB, Stockholm, Sweden

The full text article is available for purchase

$54.87 plus tax